| BIOISRAEL.com is the hub site of Israel’s life science community. BioIsrael’s Internet portal and newsletter link Israeli companies with the international biopharmaceutical and financial communities. Aiming to accelerate strategic alliances and promote investments, BioIsrael:
|
|
|
Bio-M AG Bio-M is a financing service and consulting company
with the aim to promote the development of the BioTech-Region München.
It is the “one-stop shop” for start-up biotech companies
seeking financial support, business advice and the right contacts.
Bio-M has set up a finance program to provide promising biotechnology
companies with venture capital in the initial seed and start-up
phases. |
|
|
BioTOP BioTOP is a joint initiative established by the federal states of Berlin and Brandenburg as well as the regional industry. The Aktionszentrum BioTOP is developing strategies aiming at a clear-cut commercial vision for biotechnology in the Berlin-Brandenburg area. Furthermore we offer various free services to support biotech start up companies and those who wish to settle in the region. The BioTOP-Aktionszentrum's team is at your disposal for all matters regarding biotechnology in Berlin and Brandenburg:
On the BioTOP homepage (www.biotop.de)
you will find a comprehensive overview of Berlin-Brandenburg's biotech
scene. The searchable database BioInfooffers detailed profiles of
+150 biotech companies and of over 200 teams of scientists. |
|
| BioValley Situated in the geographic heart of Europe, BioValley
implements the prospect of a trinational region in the Valley of
the Upper Rhine and which extends over North-West Switzerland, German
South Baden and French Alsace. The BioValley initiative seeks to trigger systematic
collaboration between all those involved in the process of innovation.
This calls for the creation of a network strongly committed to technology
transfer. For more information please consult:
|
|
| DIB -
German Association of Biotechnology Industries DIB is the German industry association for biotechnology, supported by the German Chemical Industry Association (VCI) and its Sector Associations for Pharmaceuticals, Diagnostics, Animal Health, Medical Devices, Crop Protection and others. DIB’s role is:
Eligible for membership in DIB are member companies of VCI and its Sector Associations which are engaged in research, development and production or render services using biotechnological methods. At present, DIB has more than 200 member companies engaged in research and production of pharmaceuticals, diagnostics, agro-biotech products, enzymes, food additives etc. DIB represents large, medium-sized, and small enterprises. DIB and its supporting organizations have quite a number of specialized committees. They take care of:
DIB’s coordinates: |
 |
Imperial
College London Innovations IC Innovations (ICIL) is the wholly owned technology transfer company of Imperial College, London, employing 23 people. It is the largest technology transfer company in the UK and particularly differentiates itself by focusing on providing extensive “hands on” support to the process of spinning out new ventures. |
 |
| Noonan
Russo Presence Noonan Russo Presence EURO RSCG is an international PR consultancy providing strategic communications counsel to pharmaceutical, healthcare and biotechnology companies. From our four locations – New York, London, San Francisco and San Diego – our integrated teams provide services spanning corporate communications, investor and media relations, strategic marketing and product communications. Since 1988 we have served clients from start-up to global leaders and have expanded and enhanced our capabilities to address the challenges within this sector. Our approach is to fully understand our clients strategic needs and provide creative and innovative solutions to ensure the transition from vision to reality. |
 |
| Zurich
MedNet Zurich MedNet is a public information resource and business development network serving the medical and biotechnology community of the Greater Zurich Area, Switzerland. Comprising more than 400 companies, universities, institutes, foundations, hospital and research labs, Zurich MedNet is the single largest medical/biotech cluster in continental Europe. Zurich MedNet offers specific services like start-up support, cooperations and strategic alliances, tech-transfer, venture capital and joint marketing initiatives. Through its webportal www.zurichmednet.org, it offers an open service platform for the virtual cluster community of medical and biotechnologies. In organizing and planning for its competitive future, Zurich MedNet has formed a strategic alliance with the University of Minnesota’s MBBNet, an information resource web portal to that US State’s virtual biomedical and bioscience community. Together, Zurich MedNet and MBBNet represent the world’s first and largest medical/bio cluster/web portal alliance, linking research and information resources for more than 1300 organizations. Further alliances in other regions of the world will be established. |
 |